Zaprinast, a type V phosphodiesterase inhibitor, dilates capacitance vessels in anaesthetised rats

Author： Ng S.S.W.   Pang C.C.Y.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.351, Iss.3, 1998-06, pp. : 323-328

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cilostazol, a selective cAMP phosphodiesterase inhibitor, dilates retinal arterioles and increases retinal and choroidal blood flow in rats

By Hotta H.   Ito H.   Kagitani F.   Sato A.  

European Journal of Pharmacology, Vol. 344, Iss. 1, 1998-02 ,pp. : 49-52

Elsevier

Access to resources Recommend Favorite

T-1032, a novel specific phosphodiesterase type 5 inhibitor, increases venous compliance in anesthetized rats

By Inoue H.   Yano K.   Ikeo T.   Noto T.   Kikkawa K.  

European Journal of Pharmacology, Vol. 422, Iss. 1, 2001-06 ,pp. : 109-114

Elsevier

Access to resources Recommend Favorite

Potency and selectivity of vardenafil: a phosphodiesterase Type 5 inhibitor

By Sommer Frank  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 1, Iss. 2, 2005-08 ,pp. : 295-301

Informa Healthcare

Access to resources Recommend Favorite

Phosphodiesterase Type 5 Inhibitor Abuse: A Critical Review

By  

Current Drug Abuse Reviews, Vol. 4, Iss. 2, 2011-06 ,pp. : 87-94

Bentham Science Publishers

Access to resources Recommend Favorite

Phosphodiesterase 5 inhibitors and nitrergic transmission-from zaprinast to sildenafil

By Gibson A.  

European Journal of Pharmacology, Vol. 411, Iss. 1, 2001-05 ,pp. : 1-10

Elsevier

Access to resources Recommend Favorite